XML 39 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes
12 Months Ended
Jun. 30, 2024
Income Taxes  
Income Taxes [Text Block]

Note 8. Income Taxes

The income tax benefit (provision) are as follows for the year ended June 30, 2024:

    Current     Deferred     Total  
2024:                  
U.S. federal $ -   $ -   $ -  
State and local   11,543     (11,543 )   -  
  $ 11,543   $ (11,543 ) $ -  

For the year ended June 30, 2023, there was no U.S. federal, state, or local income tax benefit (provision).

The components of the Company's income tax benefit are as follows for the years ended June 30:

    2024     2023  
Expected tax benefit $ 566,521   $ 1,044,407  
State taxes, net of federal tax benefit   97,884     156,392  
Valuation allowance   (664,480 )   (1,173,848 )
Incentive stock options   1,657     (22,330 )
Other, net   (1,582 )   (4,621 )
  $ -   $ -  

The Company's deferred income tax assets and (liabilities) related to the tax effects of temporary differences are as follows as of June 30:

    2024     2023  
Net deferred income tax assets (liabilities):            
Inventory capitalization for income tax purposes $ 28,642   $ 43,155  
Inventory reserve   145,227     120,153  
Accrued employee benefit reserve   40,164     43,088  
Warranty reserve   29,720     28,016  
Interest expense limitation   339,509     233,416  
Allowance for credit losses and other   35,918     85,351  
Property and equipment, principally due to differences in depreciation   108,025     27,883  
Research and development credit carryover   574,022     574,022  
Deferred gain on sale lease-back   191,436     224,777  
Operating loss carry forwards   5,388,117     4,719,831  
Valuation allowance   (6,884,228 )   (6,104,053 )
Capitalized research and development   3,448     4,361  
Total deferred income tax assets (liabilities) $ -   $ -  

Quarterly, the Company assesses the likelihood by jurisdiction that its net deferred income tax assets will be recovered. Based on the weight of all available evidence, both positive and negative, the Company records a valuation allowance against deferred income tax assets when it is more-likely-than-not that a future tax benefit will not be realized. When there is a change in judgment concerning the recovery of deferred income tax assets in future periods, a valuation allowance is recorded into earnings during the quarter in which the change in judgment occurred. As of June 30, 2024 and 2023, the Company has established a full valuation allowance.

As of June 30, 2024, the Company had federal and state operating loss carryforwards of $21.7 million and $10.5 million, respectively. The federal net operating loss carryforwards have carryforward periods that are indefinite or begin to expire in 2037. The state net operating loss carryforwards have carryforward periods that are indefinite or have various expirations. The Company has no uncertain tax positions as of June 30, 2024.